Emerging Opportunities Beyond Conventional Therapy

Platelet-rich plasma (PRP) is an autologous blood-derived product containing a higher concentration of platelets than whole blood. Upon activation, platelets release growth factors and cytokines that stimulate tissue repair, angiogenesis, and modulation of inflammation. 

PRP is widely used in veterinary orthopaedics and sports medicine. Key applications include:

• Osteoarthritis
• Tendon injuries, ligament lesions
• Fracture healing
• Wound management 
• Periodontal disease

Numerous studies have demonstrated favourable outcomes, making PRP one of the most established regenerative medicine treatments in clinical veterinary practice

Autologous conditioned serum (ACS) is produced by incubating a patient's blood under specific conditions to stimulate the production of anti-inflammatory cytokines, particularly IRAP (interleukin-1 receptor antagonist, IL-1Ra). The resulting serum is subsequently injected into affected tissues or joints, where it may help counteract inflammatory pathways associated with osteoarthritis and other degenerative joint diseases. 

ACS is especially established in equine orthopaedics but is also used in small animals.

Autologous protein solution (APS) is a biologic therapy obtained from the patient's own blood and is enriched with anti-inflammatory cytokines and growth factors. Similar to ACS, APS is intended to reduce inflammation while simultaneously providing biological mediators that support tissue repair. 

It has primarily been investigated as a treatment for osteoarthritis and other chronic musculoskeletal disorders in dogs and horses.

Tissue engineering combines cells, biomaterial scaffolds, and signalling molecules to create functional tissues that can replace or regenerate damaged structures. In veterinary medicine, current applications include:

• Cartilage repair
• Bone regeneration
• Tendon reconstruction
• Skin wound healing

The goal is to provide a structural framework that supports cell growth and facilitates the restoration of normal tissue architecture and function.

Gene therapy involves the delivery or modification of genetic material to alter cellular function and enhance tissue repair. Potential applications in veterinary medicine include:

• Stimulating the production of regenerative proteins 
• Suppressing inflammatory mediators 
• Correcting disease-associated molecular pathways

Although most veterinary gene therapy approaches remain experimental, they represent a promising future direction within regenerative medicine.

Extracellular vesicles, including exosomes, are nanosized particles naturally released by cells, particularly mesenchymal stem cells. They contain proteins, lipids, RNA, and other signalling molecules that can influence cell behaviour and promote tissue regeneration. 

Because exosomes can reproduce many of the beneficial effects of stem cells without requiring the administration of living cells, they are increasingly considered a promising next-generation, cell-free regenerative therapy.